Table 1.

Polymers used for fabrication of porous membranes in OOCs and microfluidic systems.

polymer	application
poly(dimethyl siloxane) (PDMS)	artery [6]
	erythrocyte oxygenation [7]
	gut [1,18,19]
	heart [40]
	kidney [13]
	liver [1,3,13,38]
	lung [1,11,13,42]
	multi-organ-on-chip (MOC) of liver and heart [47]
	new membranes for OOCs [52]
poly(carbonate) (PC)	blood–brain barrier (BBB) [4,43,44]
	bonding of membrane to chip [51]
	colon and breast cancer [27]
	gut [8,9]
	gut, liver and brain cancer [16]
	MOC of liver and intestine [29]
	MOC of liver and skin [29]
	multiple-layered cultures of fibroblasts, endothelial and mesenchymal cells [41]
	liver, lung and breast cancer and gut [25]
	skin [5,23]
poly(ethylene terephthalate) (PET)	gut [39]
	heart [28]
	kidney [15]
	liver [17,48]
	microfluidic barrier tissues [2]
	MOC of liver and cancer [21]
	white adipose tissue (fat) [26]
aliphatic polyesters
poly(lactic acid) (PLA)	endothelial barrier [33]
poly(ɛ-caprolactone) (PCL)	endothelial cell/pericyte/astrocyte cultures for future BBB [34]
others
poly(amide)	gut [50]
parylene C (dichloro[2,2]paracyclophane)	liver [46]
poly(tetrafluoroethylene)	liver (hepatic sinusoid) [14]
poly(urethane acrylate) (PUA)	new membranes for OOCs [52]
poly(ethylene glycol)-diacrylate (PEG-DA)	new membranes for OOCs [52]